semaglutide court ruling A South African has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Novo Nordisk scores court win

It protects cells by finding and neutralizing potentially damaging substances, such as by-products left behind by various cellular functions

Confirm how side effects should be reported and what response time to expect

Ongoing support inside your Shed portal Ask questions, request adjustments, and get support anytime from your care team

The new medication commitment pricing offer comes as Weight Watchers clinical business grows rapidly, underscoring rising demand for its integrated GLP-1 model as more consumers seek a comprehensive approach to weight health

GCN2iB can be used in research related to acute lymphoblastic leukemia, acute myeloid leukemia and diabetic cardiomyopathy